FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

23287511000001105: Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Nov 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
76659201000001112 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
76659301000001115 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has VMP Betamethasone dipropionate 0.05% / Calcipotriol 0.005% gel true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has specific active ingredient Calcipotriol monohydrate false Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has specific active ingredient Calcipotriol monohydrate true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Has basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dovobet gel (LEO Pharma) 30 gram Is a True Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Inferred relationship Existential restriction modifier
Dovobet gel (Waymade Healthcare Plc) 30 gram Is a True Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 30 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start